Literature DB >> 26645732

Synthesis and Structure-Activity Relationships of Substituted Urea Derivatives on Mouse Melanocortin Receptors.

Anamika Singh1,2, Johannes Kast2, Marvin L S Dirain2, Huisuo Huang2, Carrie Haskell-Luevano1,2.   

Abstract

The melanocortin system is involved in the regulation of several complex physiological functions. In particular, the melanocortin-3 and -4 receptors (MC3R/MC4R) have been demonstrated to regulate body weight, energy homeostasis, and feeding behavior. Synthetic and endogenous melanocortin agonists have been shown to be anorexigenic in rodent models. Herein, we report synthesis and structure-activity relationship (SAR) studies of 27 nonpeptide small molecule ligands based on an unsymmetrical substituted urea core. Three templates containing key residues from the lead compounds, showing diversity at three positions (R(1), R(2), R(3)), were designed and synthesized. The syntheses were optimized for efficient microwave-assisted chemistry that significantly reduced total syntheses time compared to a previously reported room temperature method. The pharmacological characterization of the compounds on the mouse melanocortin receptors identified compounds 1 and 12 with full agonist activity at the mMC4R, but no activity was observed at the mMC3R when tested up to 100 μM concentrations. The SAR identified compounds possessing aliphatic or saturated cyclic amines at the R(1) position, bulky aromatic groups at the R(2) position, and benzyl group at the R(3) position resulted in mMC4R selectivity over the mMC3R. The small molecule template and SAR knowledge from this series may be helpful in further design of MC3R/MC4R selective small molecule ligands.

Entities:  

Keywords:  Melanocortin receptors; melanocortin agonist; melanocortin-3 receptor; melanocortin-4 receptor; small molecules; urea ligands

Mesh:

Substances:

Year:  2015        PMID: 26645732      PMCID: PMC5726298          DOI: 10.1021/acschemneuro.5b00273

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  53 in total

1.  Analogs of MTII, lactam derivatives of alpha-melanotropin, modified at the N-terminus, and their selectivity at human melanocortin receptors 3, 4, and 5.

Authors:  M A Bednarek; T Macneil; R N Kalyani; R Tang; L H Van der Ploeg; D H Weinberg
Journal:  Biochem Biophys Res Commun       Date:  1999-07-22       Impact factor: 3.575

2.  Design and syntheses of melanocortin subtype-4 receptor agonists: evolution of the pyridazinone archetype.

Authors:  Feroze Ujjainwalla; Daniel Warner; Thomas F Walsh; Matthew J Wyvratt; Changyou Zhou; Lihu Yang; Rubana N Kalyani; Tanya MacNeil; Lex H T Van der Ploeg; Charles I Rosenblum; Rui Tang; Aurawan Vongs; David H Weinberg; Mark T Goulet
Journal:  Bioorg Med Chem Lett       Date:  2003-12-15       Impact factor: 2.823

3.  Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonist.

Authors:  Iyassu K Sebhat; William J Martin; Zhixiong Ye; Khaled Barakat; Ralph T Mosley; David B R Johnston; Raman Bakshi; Brenda Palucki; David H Weinberg; Tanya MacNeil; Rubana N Kalyani; Rui Tang; Ralph A Stearns; Randy R Miller; Constantin Tamvakopoulos; Alison M Strack; Erin McGowan; Doreen E Cashen; Jennifer E Drisko; Gary J Hom; Andrew D Howard; D Euan MacIntyre; Lex H T van der Ploeg; Arthur A Patchett; Ravi P Nargund
Journal:  J Med Chem       Date:  2002-10-10       Impact factor: 7.446

4.  Structure-activity relationships of melanocortin agonists containing the benzimidazole scaffold.

Authors:  Aleksandar Todorovic; Christine G Joseph; Nicholas B Sorensen; Michael S Wood; Carrie Haskell-Luevano
Journal:  Chem Biol Drug Des       Date:  2007-05       Impact factor: 2.817

5.  Targeted disruption of the melanocortin-4 receptor results in obesity in mice.

Authors:  D Huszar; C A Lynch; V Fairchild-Huntress; J H Dunmore; Q Fang; L R Berkemeier; W Gu; R A Kesterson; B A Boston; R D Cone; F J Smith; L A Campfield; P Burn; F Lee
Journal:  Cell       Date:  1997-01-10       Impact factor: 41.582

6.  A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse.

Authors:  A A Butler; R A Kesterson; K Khong; M J Cullen; M A Pelleymounter; J Dekoning; M Baetscher; R D Cone
Journal:  Endocrinology       Date:  2000-09       Impact factor: 4.736

7.  The cloning of a family of genes that encode the melanocortin receptors.

Authors:  K G Mountjoy; L S Robbins; M T Mortrud; R D Cone
Journal:  Science       Date:  1992-08-28       Impact factor: 47.728

8.  Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA.

Authors:  V Chhajlani; J E Wikberg
Journal:  FEBS Lett       Date:  1992-09-14       Impact factor: 4.124

9.  A colorimetric assay for measuring activation of Gs- and Gq-coupled signaling pathways.

Authors:  W Chen; T S Shields; P J Stork; R D Cone
Journal:  Anal Biochem       Date:  1995-04-10       Impact factor: 3.365

10.  4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity.

Authors:  T K Sawyer; P J Sanfilippo; V J Hruby; M H Engel; C B Heward; J B Burnett; M E Hadley
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

View more
  2 in total

Review 1.  Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016.

Authors:  Mark D Ericson; Cody J Lensing; Katlyn A Fleming; Katherine N Schlasner; Skye R Doering; Carrie Haskell-Luevano
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-29       Impact factor: 5.187

2.  Discovery of Nanomolar Melanocortin-3 Receptor (MC3R)-Selective Small Molecule Pyrrolidine Bis-Cyclic Guanidine Agonist Compounds Via a High-Throughput "Unbiased" Screening Campaign.

Authors:  Skye R Doering; Katie Freeman; Ginamarie Debevec; Phaedra Geer; Radleigh G Santos; Travis M Lavoi; Marc A Giulianotti; Clemencia Pinilla; Jon R Appel; Richard A Houghten; Mark D Ericson; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2021-04-22       Impact factor: 7.446

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.